Amnesty International denounces the unfair management of Pfizer towards poor countries

According to the NGO, the American laboratory produces “misleading statements” and only provides a minimum portion of its doses to “low-income” countries.

The unequal distribution of vaccines in the fight against Covid-19 throughout the world, and in particular in the poorest countries, was not in doubt. Amnesty International confirms this Thursday by pointing out the unfair management and while com ‘of Pfizer, pointing to the “Misleading statements” of the pharmaceutical giant. In a statement, the association for the defense of human rights assures that the American lab “Proclaim loud and clear that by the end of the year, [il] will have delivered at least one billion doses to low- and middle-income nations, “” the bulk of Pfizer’s vaccine doses have actually landed in ‘upper-middle-income’ countries like Malaysia, Mexico and the United States. Thailand”. Thus disregarding the countries which are part of the categories to be “low income”, and “Lower middle income”. Either the poorest on the planet.

According to Amnesty International, and according to figures provided by Pfizer, the laboratory sent a total of two billion doses, of which only 154 million doses (8% of the total) to 42 low- and lower-middle-income countries (15 , 4 million to low-income countries).

Moderna and Johnson & Johnson also pinned

According to Patrick Wilcken, head of the NGO’s Business, Security and Human Rights program, “These companies may attempt to manipulate the facts, but the figures speak for themselves: they continue to ship most of their doses to wealthy regions of the globe.”

Amnesty International is not just beating down on Pfizer: the NGO is also pinning down other laboratories that provide Covid vaccines. Based on data provided by Airfinity, a science analysis company, Amnesty says Moderna and Johnson & Johnson also have a poor track record in equitable distribution of their vaccines: “In the last fifty days, only 100,000 of the 52 million doses provided [par Moderna] arrived in low-income countries. ” As for Johnson & Johnson, the laboratory would have delivered only “11% of its vaccines to low income countries, and 5% to lower middle income countries.”

Source: Libération by

*The article has been translated based on the content of Libération by If there is any problem regarding the content, copyright, please leave a report below the article. We will try to process as quickly as possible to protect the rights of the author. Thank you very much!

*We just want readers to access information more quickly and easily with other multilingual content, instead of information only available in a certain language.

*We always respect the copyright of the content of the author and always include the original link of the source article.If the author disagrees, just leave the report below the article, the article will be edited or deleted at the request of the author. Thanks very much! Best regards!